Lecture
Academic literature review
Academic article
-
Trine Kåsine; Anne Margarita Dyrhol Riise; Andreas Barratt-Due
et al. (2021). Neutrophil count predicts outcome in hospitalized COVID-19 patients. Results from the NOR-Solidarity trial. (external link)
-
Nina Urke Ertesvåg; Julie Xiao; Fan Zhou
et al. (2022). A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern. (external link)
-
Mai Chi Trieu; Amit Bansal; Anders Madsen
et al. (2020). SARS-CoV-2-specific neutralizing antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study. (external link)
-
Jannik Stemler; Lusine Yeghiazaryan; Christoph Stephan
et al. (2024). Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B). (external link)
-
Kristin Greve Isdahl Mohn; Karl Albert Brokstad; Rishi Pathirana
et al. (2016). Live attenuated influenza vaccine in children induces b-cell responses in tonsils. (external link)
-
Stella G. Muthuri; Sudhir Venkatesan; Puja R. Myles
et al. (2016). Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis. (external link)
-
Jorge Jacob; Tor Biering-Sørensen; Lars Holger Ehlers
et al. (2023). Cost-Effectiveness of Vaccination of Older Adults with an MF59<sup>®</sup>-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden. (external link)
-
Nina Urke Ertesvåg; Rebecca Jane Cox; Sarah Larteley Lartey Jalloh
et al. (2022). Seasonal influenza vaccination expands hemagglutinin-specific antibody breadth to older and future A/H3N2 viruses. (external link)
-
Valeria Napolitano; Agnieszka Dabrowska; Kenji Schorpp
et al. (2022). Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. (external link)
-
Heidi Syre; Marius Eduardo Brå Obreque; Ingvild Dalen
et al. (2022). The performances of three commercially available assays for the detection of SARS‐CoV‐2 antibodies at different time points following SARS‐CoV‐2 infection. (external link)
-
Therese Bredholt Onyango; Fan Zhou; Geir Bredholt
et al. (2023). SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients. (external link)
-
Jack Alwin Panapasa; Rebecca Jane Cox; Kristin Greve Isdahl Mohn
et al. (2015). The expression of B & T cell activation markers in children’s tonsils following live attenuated influenza vaccine. (external link)
-
Amit Bansal; Mai Chi Trieu; Kristin Greve-Isdahl Mohn
et al. (2023). Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers. (external link)
-
Abdullah Sami Madhun; Per Espen Akselsen; Haakon Sjursen
et al. (2010). An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. (external link)
-
Kristin Greve-Isdahl Mohn; Birger Norderud Lærum; Steinar Skrede
et al. (2013). Reduced Hospital Stay in Influenza Patients after Mass Vaccination during the 2009 Influenza Pandemic in Norway. (external link)
-
Sudhir Venkatesan; Puja R. Myles; Kirsty J. Bolton
et al. (2020). Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection. (external link)
-
Anette Susanne Bøe Wolff; Lena Hansen; Marianne Aardal Grytaas
et al. (2023). Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies. (external link)
-
Elisabeth Berg Fjelltveit; Rebecca Jane Cox Brokstad; Jørgen Østensjø
et al. (2020). Point-of-care influenza testing impacts clinical decision, patient flow and length of stay in hospitalized adults. (external link)
-
Nina Urke Ertesvåg; Arild Iversen; Bjørn Blomberg
et al. (2023). Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents. (external link)
-
Amit Bansal; Mai Chi Trieu; Kristin Greve-Isdahl Mohn
et al. (2021). Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review. (external link)
-
Shahinul Islam; Kristin Greve Isdahl Mohn; Florain Krammer
et al. (2017). Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination. (external link)
-
Shahinul Islam; Fan Zhou; Sarah Larteley Lartey Jalloh
et al. (2019). Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination. (external link)
-
Elisabeth Berg Fjelltveit; Bjørn Blomberg; Kanika Kuwelker
et al. (2022). Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study. (external link)
-
Kanika Kuwelker; Fan Zhou; Bjørn Blomberg
et al. (2021). Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study. (external link)
-
Fan Zhou; Juha Vahokoski; Siri Øyen
et al. (2024). Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection. (external link)
-
Irina Meln; Victor Cnossen; Nicoletta Corti
et al. (2025). Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies – A stakeholder meeting report. (external link)
-
Lena Hansen; Karl Albert Brokstad; Amit Bansal
et al. (2023). Durable immune responses after BNT162b2 vaccination in home-dwelling old adults. (external link)
-
John Mair-Jenkins; Maria Saavedra-Campos; J. Kenneth Baillie
et al. (2015). The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: A systematic review and exploratory meta-analysis. (external link)
-
Gemma Pidelaserra Marti; Kristin Greve Isdahl Mohn; Rebecca Jane Cox
et al. (2014). The Influence of Tonsillectomy on Total Serum Antibody Levels. (external link)
-
Kristin Greve Isdahl Mohn; Karl Albert Brokstad; Shahinul Islam
et al. (2020). Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children. (external link)
-
Bjørn Blomberg; Kristin Greve-Isdahl Mohn; Karl Albert Brokstad
et al. (2021). Long COVID in a prospective cohort of
home-isolated patients. (external link)
-
Nina Urke Ertesvåg; Sunniva Todnem Sakkestad; Fan Zhou
et al. (2022). Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment. (external link)
-
Sarah Larteley Lartey Jalloh; Fan Zhou; Karl Albert Brokstad
et al. (2020). Live-attenuated influenza vaccine induces tonsillar
follicular T helper cell responses that correlate with
antibody induction. (external link)
-
Hans-Kittil Viermyr; Bente Halvorsen; Ellen Lund Sagen
et al. (2024). High viral loads combined with inflammatory markers predict disease severity in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial. (external link)
-
Alessandro Manenti; Sarah Tete; Kristin Greve Isdahl Mohn
et al. (2016). Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination. (external link)
-
Kristin Greve Isdahl Mohn; Rebecca Jane Cox; Gro Tunheim
et al. (2015). Immune responses in acute and convalescent patients with mild, moderate and severe disease during the 2009 influenza pandemic in Norway. (external link)
-
Geir Bredholt; Marianne Sævik; Hanne Søyland
et al. (2024). Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adults. (external link)
-
Elisabeth Berg Fjelltveit; Rebecca Jane Cox; Bård Reiakvam Kittang
et al. (2021). Lower antibiotic prescription rates in hospitalized COVID-19 patients than influenza patients, a prospective study. (external link)
-
Stella G. Muthuri; Sudhir Venkatesan; Puja R Myles
et al. (2014). Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-analysis of individual participant data. (external link)
-
Abira Paramsothy; Sarah Larteley Lartey Jalloh; Richard Allan Davies
et al. (2021). Humoral and cellular immune responses in critically ill influenza A/H1N1-infected patients. (external link)
-
Kristin Greve-Isdahl Mohn; Geir Bredholt; Fan Zhou
et al. (2022). Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients. (external link)
-
Kristin Greve Isdahl Mohn; Geir Bredholt; Karl Albert Brokstad
et al. (2015). Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children. (external link)
-
Lukas Anders Kryger Hoen; Sarah Larteley Lartey Jalloh; Fan Zhou
et al. (2024). Impact of Pre-Existing Immunity and Age on Antibody Responses to Live Attenuated Influenza Vaccine. (external link)
-
Kristin Greve Isdahl Mohn; Fan Zhou; Karl Albert Brokstad
et al. (2017). Boosting of cross-reactive and protection-associated T cells in children after live attenuated influenza vaccination. (external link)
Media interview
Media feature article
Letter to the editor
Radio or TV participation
Doctoral thesis (PhD)
Conference poster
Conference lecture
Professional article
Popular science article
Journal review
See a complete overview of publications in Cristin.